Trial Profile
A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Jul 2011
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Rosiglitazone
- Indications Multiple sclerosis; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Solvay Pharmaceuticals
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
- 20 Mar 2010 New trial record